Skip to main content
. 2015 Aug 21;6(30):29268–29284. doi: 10.18632/oncotarget.4922

Figure 5. Poorer survival rates in head and neck cancer patients with diabetes and lymph node metastasis.

Figure 5

Kaplan-Meier survival analysis for A. cancer-specific survival rates and B. disease free survival rates between DM (N = 126) and non-DM subjects (N = 487) (p < 0.0001) and cumulative cancer-specific survival rates of C. DM patients with differential HbA1c status (p < 0.001) and D. groups associated with neck lymph node status in DM patients and non-DM subjects (p < 0.0001).